13.50
+0.01(+0.07%)
Currency In USD
| Previous Close | 13.49 |
| Open | 13.5 |
| Day High | 13.65 |
| Day Low | 13.2 |
| 52-Week High | 18.98 |
| 52-Week Low | 7.56 |
| Volume | 182,101 |
| Average Volume | 191,198 |
| Market Cap | 449.61M |
| PE | -18 |
| EPS | -0.75 |
| Moving Average 50 Days | 10.62 |
| Moving Average 200 Days | 11.28 |
| Change | 0.01 |
If you invested $1000 in NeuroPace, Inc. (NPCE) since IPO date, it would be worth $540.87 as of November 13, 2025 at a share price of $13.5. Whereas If you bought $1000 worth of NeuroPace, Inc. (NPCE) shares 3 years ago, it would be worth $6,818.18 as of November 13, 2025 at a share price of $13.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
GlobeNewswire Inc.
Aug 01, 2025 11:30 AM GMT
MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers
NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire Inc.
Jul 29, 2025 8:05 PM GMT
MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the second quar
NeuroPace Announces Strategic CFO Transition
GlobeNewswire Inc.
Jun 24, 2025 8:05 PM GMT
Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory Role MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NE